Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese Ministry Of Health Looks To Revise OTC Retailing Regulations

This article was originally published in The Tan Sheet

Executive Summary

Risk-based classification for OTC drugs in Japan is an issue that will figure prominently during a Nov. 15 meeting of a Working Group established by the government's "Task Force to Study Pharmaceutical Retailing.

You may also be interested in...



OTCs in Japan

Over-the-counter drugs may be sold in Japan when pharmacists are not present in stores, provided that a staff member at the retail outlet consults with an on-call pharmacist through videophone, the Japanese Ministry of Health, Labour & Welfare decides in a Jan. 22 report. The "deregulation" will result in the late-night sale of OTCs from 10 pm to 6 am, when pharmacists are not on staff, according to a spokesperson from the Japanese Embassy. In a recent letter, CHPA urged the U.S. Trade Representative to consider distribution restrictions on nonprescription drugs in Japan as a trade barrier to entry for American firms (1"The Tan Sheet" Jan. 5, 2004, p. 10)...

Japan OTC Retail, Advertising Barriers Should Be Addressed By USTR – CHPA

The Consumer Healthcare Products Association urges the U.S. Trade Representative in recent comments "to draw attention to OTC medicine distribution restrictions" in Japan as an "indirect barrier to market entry" in its upcoming annual report on foreign trade barriers

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS097517

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel